These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7909787)

  • 1. Glucocorticoids stabilize HER-2/neu messenger RNA in human epithelial ovarian carcinoma cells.
    Karlan BY; Jones J; Slamon DJ; Lagasse LD
    Gynecol Oncol; 1994 Apr; 53(1):70-7. PubMed ID: 7909787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid hormonal independence of HER-2/neu mRNA expression in four human ovarian carcinoma cell lines.
    Jones J; Lagasse LD; Karlan BY
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):421-6. PubMed ID: 7835782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.
    Yu D; Wolf JK; Scanlon M; Price JE; Hung MC
    Cancer Res; 1993 Feb; 53(4):891-8. PubMed ID: 8094034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary evaluation of HER-2/neu oncogene and epidermal growth factor receptor expression in normal and neoplastic human ovaries.
    Mileo AM; Fanuele M; Battaglia F; Scambia G; Benedetti-Panici C; Mattei E; Mancuso S; Delpino A
    Int J Biol Markers; 1992; 7(1):47-51. PubMed ID: 1349908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor reduces HER-2 protein level in human ovarian carcinoma cells.
    Marth C; Lang T; Cronauer MV; Doppler W; Zeimet AG; Bachmair F; Ullrich A; Daxenbichler G
    Int J Cancer; 1992 Sep; 52(2):311-6. PubMed ID: 1355758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells.
    Pietras RJ; Fendly BM; Chazin VR; Pegram MD; Howell SB; Slamon DJ
    Oncogene; 1994 Jul; 9(7):1829-38. PubMed ID: 7911565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of the c-erbB-2/neu protooncogene in ovarian cancer.
    Hung MC; Zhang X; Yan DH; Zhang HZ; He GP; Zhang TQ; Shi DR
    Cancer Lett; 1992 Jan; 61(2):95-103. PubMed ID: 1346099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoids inhibit cell death in ovarian cancer and up-regulate caspase inhibitor cIAP2.
    Runnebaum IB; Brüning A
    Clin Cancer Res; 2005 Sep; 11(17):6325-32. PubMed ID: 16144937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of interferons on the expression of the proto-oncogene HER-2 in human ovarian carcinoma cells.
    Marth C; Cronauer MV; Doppler W; Ofner D; Ullrich A; Daxenbichler G
    Int J Cancer; 1992 Jan; 50(1):64-8. PubMed ID: 1370227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists.
    Chatzistamou I; Schally AV; Sun B; Armatis P; Szepeshazi K
    Br J Cancer; 2000 Oct; 83(7):906-13. PubMed ID: 10970693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER-2/neu and bcl-2 in ovarian carcinoma: clinicopathologic, immunohistochemical, and molecular study in patients with shorter and longer survival.
    Raspollini MR; Amunni G; Villanucci A; Castiglione F; Rossi Degl'Innocenti D; Baroni G; Paglierani M; Taddei GL
    Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):181-6. PubMed ID: 16785787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Messenger RNA decay of macrophage colony-stimulating factor in human ovarian carcinomas in vitro.
    Chambers SK; Kacinski BM
    J Soc Gynecol Investig; 1994; 1(4):310-6. PubMed ID: 9419789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neu proto-oncogene amplification and expression in ovarian adenocarcinoma cell lines.
    King BL; Carter D; Foellmer HG; Kacinski BM
    Am J Pathol; 1992 Jan; 140(1):23-31. PubMed ID: 1346236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells.
    Aguilar Z; Akita RW; Finn RS; Ramos BL; Pegram MD; Kabbinavar FF; Pietras RJ; Pisacane P; Sliwkowski MX; Slamon DJ
    Oncogene; 1999 Oct; 18(44):6050-62. PubMed ID: 10557094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Her-2/NEU in epithelial ovarian carcinoma induces vascular endothelial growth factor C by activating NF-kappa B: implications for malignant ascites formation and tumor lymphangiogenesis.
    Hsieh CY; Chen CA; Chou CH; Lai KP; Jeng YM; Kuo ML; Wei LH
    J Biomed Sci; 2004; 11(2):249-59. PubMed ID: 14966375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.
    Slamon DJ; Godolphin W; Jones LA; Holt JA; Wong SG; Keith DE; Levin WJ; Stuart SG; Udove J; Ullrich A
    Science; 1989 May; 244(4905):707-12. PubMed ID: 2470152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER-2/neu oncogene characterization in head and neck squamous cell carcinoma.
    Beckhardt RN; Kiyokawa N; Xi L; Liu TJ; Hung MC; el-Naggar AK; Zhang HZ; Clayman GL
    Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1265-70. PubMed ID: 7576473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interferon-gamma suppresses expression of the HER-2 oncogene in ovarian cancer cells].
    Marth C; Müller-Holzner E; Zeimet AG; Greiter E; Cronauer MV; Doppler W; Eibl B; Hynes NE; Daxenbichler G
    Gynakol Geburtshilfliche Rundsch; 1992; 32(1):31-4. PubMed ID: 1355379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of the C-erbB-2(HER-2/neu) proto-oncogene in ovarian carcinomas.
    Fan QB; Bian ML; Huang SZ; Lang JH; Ma J; Liu WS; Xu XY
    Chin Med J (Engl); 1994 Aug; 107(8):589-93. PubMed ID: 7805442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of doxorubicin to ES-2 human ovarian cancers in nude mice by linking to an analog of luteinizing hormone-releasing hormone improves its effectiveness.
    Arencibia JM; Schally AV; Krupa M; Bajo AM; Nagy A; Szepeshazi K; Plonowski A
    Int J Oncol; 2001 Sep; 19(3):571-7. PubMed ID: 11494038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.